STERIS stock has significantly underperformed the Nasdaq over the past 52 weeks, yet analysts remain strongly bullish on the stock’s prospects.
Zimmer Biomet Holdings has significantly underperformed other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.
Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.
While Zimmer Biomet has lagged behind the broader market over the past year, analysts continue to hold a moderately positive view on the stock's prospects.
Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. Yet, factors like macroeconomic uncertainties put pressure on the bottom line. The stock...
Zimmer Biomet Holdings is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings growth.
Smith & Nephew SNATSÂ SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions,...
Morningstar recently ranked the 10 most undervalued stocks to buy in October. I found three unusually active options that stood out as attractive bets on these struggling stocks.
Solventum outperformed the broader market recently, but Wall Street analysts remain cautious about the stock’s prospects.